Clinical trial
A Phase 1, First in Human, Randomized, Placebo-controlled Trial With a Controlled Gluten Challenge to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of VTP-1000 in Adults With Celiac Disease
NCT06310291 is registered in ClinicalTrials.gov with Barinthus Biotherapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1, First in Human, Randomized, Placebo-controlled Trial With a Controlled Gluten Challenge to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of VTP-1000 in Adults With Celiac Disease
- Lead sponsor
- Barinthus Biotherapeutics
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- August 1, 2024
- Completion date
- November 30, 2026
- Enrollment
- 45 (estimated)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.